WINNERS & LOSERS: Bunzl backs outlook; Reckitt sales fall
(Alliance News) - The following are the leading risers and fallers among FTSE 100 and 250 index constituents on Wednesday. Read More
| Price | 595.00p on 24-04-2026 at 07:50:52 |
|---|---|
| Change | -15.00p -2.46% |
| Buy | 600.00p |
| Sell | 595.00p |
| Last Trade: | Sell 415.00 at 595.00p |
| Day's Volume: | 41,742 |
| Last Close: | 610.00p |
| Open: | 607.00p |
| ISIN: | GB00BMX64W89 |
| Day's Range | 595.00p - 608.00p |
| 52wk Range: | 130.00p - 652.00p |
| Market Capitalisation: | £856.54m |
| VWAP: | 600.81861p |
| Shares in Issue: | 143.96m |
Saga (SAGA) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Sell* | 415 | 595.00p | Automatic Execution |
08:50:52 - 24-Apr-26 |
| Buy* | 22 | 596.00p | Automatic Execution |
08:49:47 - 24-Apr-26 |
| Buy* | 478 | 596.00p | Automatic Execution |
08:49:46 - 24-Apr-26 |
| Sell* | 159 | 595.00p | Automatic Execution |
08:49:46 - 24-Apr-26 |
| Unknown* | 1,847 | 597.00p | Ordinary |
08:48:32 - 24-Apr-26 |
| Unknown* | 31 | 597.00p | Ordinary |
08:47:35 - 24-Apr-26 |
| Sell* | 1,189 | 595.00p | SI Trade |
08:43:06 - 24-Apr-26 |
| Sell* | 4,000 | 596.604p | Ordinary |
08:41:15 - 24-Apr-26 |
| Buy* | 5 | 599.00p | SI Trade |
08:39:31 - 24-Apr-26 |
| Buy* | 82 | 599.98p | Ordinary |
08:36:09 - 24-Apr-26 |
Saga (SAGA) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 23rd Apr 2026 4:42 pm | RNS | Director/PDMR Shareholding |
| 23rd Apr 2026 4:40 pm | RNS | Director/PDMR Shareholding |
| 15th Apr 2026 7:00 am | RNS | Preliminary results for the year ended 31 Jan 2026 |
| 23rd Mar 2026 1:59 pm | RNS | Committee Changes |
| 3rd Mar 2026 7:00 am | RNS | Appointment of Joint Corporate Brokers |
| 27th Feb 2026 4:00 pm | RNS | Directorate change |
| 29th Jan 2026 7:00 am | RNS | Trading Update |
| 16th Dec 2025 7:00 am | RNS | Saga and Ageas Insurance partnership goes live |
| 30th Sep 2025 2:40 pm | RNS | Holding(s) in Company |
| 29th Sep 2025 10:15 am | RNS | Director/PDMR Shareholding |